Skip to main content

Podcasts


Listen to podcasts with clinical experts discussing key issues in rheumatology.


Repurposing rheumatology drugs for COVID-19: TNF inhibitors

Philip Robinson discusses why TNF inhibitors may be a favorable treatment option for COVID-19 and outlines the trials that are currently underway (16:39).

Philip Robinson

09-03-2021 | COVID-19 | Podcast | Article

Repurposing rheumatology drugs for COVID-19: TNF inhibitors

Philip Robinson discusses why TNF inhibitors may be a favorable treatment option for COVID-19 and outlines the trials that are currently underway (16:39).

Cristina Mussini

11-02-2021 | COVID-19 | Podcast | Article

Repurposing rheumatology drugs for COVID-19: Interleukin inhibitors

Cristina Mussini discusses the current data on interleukin inhibitors for the treatment of COVID-19 and explores why tocilizumab has been associated with beneficial outcomes in some studies but not others (19:10).

Marwan Bukhari

25-01-2021 | COVID-19 | Podcast | Article

Repurposing rheumatology drugs for COVID-19: JAK inhibitors

Marwan Bukhari talks about the rationale behind investigating baricitinib and other JAK inhibitors for the treatment of COVID-19 and outlines the current efficacy data (10:42).

Al Kim

12-01-2021 | COVID-19 | Podcast | Article

Repurposing rheumatology drugs for COVID-19: Hydroxychloroquine

Alfred Kim talks about the initial promise of hydroxychloroquine for COVID-19 and why it did not stand up to later scrutiny (13:06).

Jinoos Yazdany

17-12-2020 | COVID-19 | Podcast | Article

Repurposing rheumatology drugs for COVID-19: What do we know?

In the introductory podcast for our series on repurposing rheumatology drugs for COVID-19, Jinoos Yazdany discusses the rationale behind investigating these agents and explores the role of rheumatologists in ensuring they are studied as safely and efficiently as possible (13:07).

Ted Mikuls

13-05-2020 | COVID-19 | Podcast | Article

A closer look at the ACR guidance on COVID-19 and rheumatology care

Ted Mikuls, lead author on the ACR guidance for the management of patients with rheumatic disease during the COVID-19 pandemic, talks about how rheumatologists should best care for their patients at this time and explores some of the unanswered questions (8:08).

COVID-19 registry podcast

01-04-2020 | COVID-19 | Podcast | Article

The COVID-19 Global Rheumatology Alliance registry: What you need to know

Philip Robinson, chair of the steering committee for the COVID-19 Global Rheumatology Alliance, tells us about the initiative that will enable rheumatologists to document their patient experiences of COVID-19 and contribute to a shared learning resource (17:28).

COVID-19 podcast

27-03-2020 | COVID-19 | Podcast | Audio

COVID-19: A pediatric rheumatologist’s perspective

Sangeeta Sule, from Children’s National Hospital in Washington, DC, USA, shares her experience of how the pediatric rheumatology community is adapting to the COVID-19 pandemic, including the use of telemedicine practices (9:06).

coronavirus Covid-19 virus in a laboratory

24-03-2020 | Infection | Podcast | Article

COVID-19 in people with rheumatic diseases

Kevin Winthrop, from Oregon Health & Science University in Portland, USA, discusses why patients with rheumatic diseases may be vulnerable to COVID-19 and how different treatments may affect the risk for infection and prognosis of the disease (10:31).

Philip Mease

01-11-2019 | Psoriatic arthritis | ACR/ARP 2019 | Article

Researcher comment: The DISCOVER-2 trial

Lead investigator Philip Mease outlines the results of the DISCOVER-2 trial, and discusses how guselkumab may impact the psoriatic arthritis treatment landscape (8:26).

Our podcasts are also available on...